VERTEX PHARMACEUTICALS INC's ticker is and the CUSIP is 92532F900. A total of 7 filers reported holding VERTEX PHARMACEUTICALS INC in Q1 2016. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2016 | $4,361,000 | +8.0% | 50,700 | -0.2% | 0.01% | 0.0% |
| Q1 2016 | $4,038,000 | -25.4% | 50,800 | +18.1% | 0.01% | -16.7% |
| Q4 2015 | $5,411,000 | -13.0% | 43,000 | -28.0% | 0.01% | 0.0% |
| Q3 2015 | $6,217,000 | +5.8% | 59,700 | +25.4% | 0.01% | +20.0% |
| Q2 2015 | $5,878,000 | +2.9% | 47,600 | -1.7% | 0.01% | 0.0% |
| Q1 2015 | $5,710,000 | -54.7% | 48,400 | -54.4% | 0.01% | -58.3% |
| Q4 2014 | $12,605,000 | +0.8% | 106,100 | -4.8% | 0.01% | -7.7% |
| Q3 2014 | $12,511,000 | -11.8% | 111,400 | -25.6% | 0.01% | -18.8% |
| Q2 2014 | $14,183,000 | +23.8% | 149,800 | -7.5% | 0.02% | +23.1% |
| Q1 2014 | $11,457,000 | -5.7% | 162,000 | -1.0% | 0.01% | -18.8% |
| Q4 2013 | $12,155,000 | +40.4% | 163,600 | +43.3% | 0.02% | +23.1% |
| Q3 2013 | $8,659,000 | +41.7% | 114,200 | +49.3% | 0.01% | +18.2% |
| Q2 2013 | $6,110,000 | – | 76,500 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| WINTRUST INVESTMENTS LLC | 2,700 | $492,000 | 0.05% |
| GROUP ONE TRADING, L.P. | 153,800 | $40,137,000 | 0.04% |
| SG Americas Securities, LLC | 100,500 | $3,032,000 | 0.02% |
| SIMPLEX TRADING, LLC | 69,500 | $18,137,000 | 0.02% |
| IMC-Chicago, LLC | 18,200 | $4,750,000 | 0.01% |
| HRT FINANCIAL LP | 900 | $234,000 | 0.00% |
| Allianz Asset Management GmbH | 800 | $209,000 | 0.00% |
| JPMORGAN CHASE & CO | 15,000 | $3,915,000 | 0.00% |
| CONCOURSE FINANCIAL GROUP SECURITIES, INC. | 0 | $0 | 0.00% |